News
The company is using the supply chain traceability system from Netherlands-based Circularise B.V., in which Teijin has invested since November 2024, to develop DPPs for each product. Implementation of ...
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...
In the company’s exhibit, Teijin will present its high-performance materials and composites technologies that can improve manufacturing cycle times, reduce environmental impact and improve consumer ...
Teijin Pharma Ltd. has identified crystalline forms of oxazepine derivatives acting as orexin OX2 receptor agonists reported to be useful for the treatment of narcolepsy, hypersomnia and sleep apnea.
DuPont Teijin Films has launched a new depolymerization process which "upcycles" post-consumer PET waste into technically-advanced biaxially oriented PET films suitable for use in various ...
Listed below are the charts and positions for Teijin Ltd in this year’s pharmaceutical sales data alongside recent articles on PMLiVE featuring Teijin Ltd. GlobalData provides trusted intelligence on ...
Merck & Co is looking to improve its neurology pipeline via a deal with Teijin Pharma to develop a new tau-targeting antibody. The tau protein is implicated in a number of nervous system ...
Teijin Pharma is part of Teijin Group, a multinational offering services in high-performance materials, healthcare including pharma and IT. It comprises more than 170 companies and employs 20,000 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results